Docking, Interaction Fingerprint, and Three-Dimensional Quantitative Structure–Activity Relationship (3D-QSAR) of Sigma1 Receptor Ligands, Analogs of the Neuroprotective Agent RC-33
The human Sigma1 receptor (S1R), which has been identified as a target with an important role in neuropsychological disorders, was first crystallized 3 years ago. Since S1R structure has no relation with another previous crystallized structures, the presence of the new crystal is an important hallma...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-07-01
|
Series: | Frontiers in Chemistry |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fchem.2019.00496/full |
id |
doaj-f201896eb2b24e4ba2ad186dfb9c1cd3 |
---|---|
record_format |
Article |
spelling |
doaj-f201896eb2b24e4ba2ad186dfb9c1cd32020-11-25T01:43:07ZengFrontiers Media S.A.Frontiers in Chemistry2296-26462019-07-01710.3389/fchem.2019.00496465769Docking, Interaction Fingerprint, and Three-Dimensional Quantitative Structure–Activity Relationship (3D-QSAR) of Sigma1 Receptor Ligands, Analogs of the Neuroprotective Agent RC-33José Luis Velázquez-Libera0Giacomo Rossino1Carlos Navarro-Retamal2Simona Collina3Julio Caballero4Centro de Bioinformática y Simulación Molecular, Facultad de Ingeniería, Universidad de Talca, Talca, ChilePharmaceutical and Medicinal Chemistry Section, Drug Sciences Department, Università di Pavia, Pavia, ItalyCentro de Bioinformática y Simulación Molecular, Facultad de Ingeniería, Universidad de Talca, Talca, ChilePharmaceutical and Medicinal Chemistry Section, Drug Sciences Department, Università di Pavia, Pavia, ItalyCentro de Bioinformática y Simulación Molecular, Facultad de Ingeniería, Universidad de Talca, Talca, ChileThe human Sigma1 receptor (S1R), which has been identified as a target with an important role in neuropsychological disorders, was first crystallized 3 years ago. Since S1R structure has no relation with another previous crystallized structures, the presence of the new crystal is an important hallmark for the design of agonists and antagonists against this important target. Some years ago, our group identified RC-33, a potent and selective S1R agonist, endowed with neuroprotective properties. In this work, drawing on new structural information, we studied the interactions of RC-33 and its analogs with the S1R binding site by using computational methods such as docking, interaction fingerprints, and receptor-guided alignment three dimensional quantitative structure–activity relationship (3D-QSAR). We found that RC-33 and its analogs adopted similar orientations within S1R binding site, with high similitude with orientations of the crystallized ligands; such information was used for identifying the residues involved in chemical interactions with ligands. Furthermore, the structure-activity relationship of the studied ligands was adequately described considering classical QSAR tests. All relevant aspects of the interactions between the studied compounds and S1R were covered here, through descriptions of orientations, binding interactions, and features that influence differential affinities. In this sense, the present results could be useful in the future design of novel S1R modulators.https://www.frontiersin.org/article/10.3389/fchem.2019.00496/fullsigma1 receptor ligandsRC-33arylalkylamine derivatesdockingquantitative structure–activity relationshipsinteraction fingerprints |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
José Luis Velázquez-Libera Giacomo Rossino Carlos Navarro-Retamal Simona Collina Julio Caballero |
spellingShingle |
José Luis Velázquez-Libera Giacomo Rossino Carlos Navarro-Retamal Simona Collina Julio Caballero Docking, Interaction Fingerprint, and Three-Dimensional Quantitative Structure–Activity Relationship (3D-QSAR) of Sigma1 Receptor Ligands, Analogs of the Neuroprotective Agent RC-33 Frontiers in Chemistry sigma1 receptor ligands RC-33 arylalkylamine derivates docking quantitative structure–activity relationships interaction fingerprints |
author_facet |
José Luis Velázquez-Libera Giacomo Rossino Carlos Navarro-Retamal Simona Collina Julio Caballero |
author_sort |
José Luis Velázquez-Libera |
title |
Docking, Interaction Fingerprint, and Three-Dimensional Quantitative Structure–Activity Relationship (3D-QSAR) of Sigma1 Receptor Ligands, Analogs of the Neuroprotective Agent RC-33 |
title_short |
Docking, Interaction Fingerprint, and Three-Dimensional Quantitative Structure–Activity Relationship (3D-QSAR) of Sigma1 Receptor Ligands, Analogs of the Neuroprotective Agent RC-33 |
title_full |
Docking, Interaction Fingerprint, and Three-Dimensional Quantitative Structure–Activity Relationship (3D-QSAR) of Sigma1 Receptor Ligands, Analogs of the Neuroprotective Agent RC-33 |
title_fullStr |
Docking, Interaction Fingerprint, and Three-Dimensional Quantitative Structure–Activity Relationship (3D-QSAR) of Sigma1 Receptor Ligands, Analogs of the Neuroprotective Agent RC-33 |
title_full_unstemmed |
Docking, Interaction Fingerprint, and Three-Dimensional Quantitative Structure–Activity Relationship (3D-QSAR) of Sigma1 Receptor Ligands, Analogs of the Neuroprotective Agent RC-33 |
title_sort |
docking, interaction fingerprint, and three-dimensional quantitative structure–activity relationship (3d-qsar) of sigma1 receptor ligands, analogs of the neuroprotective agent rc-33 |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Chemistry |
issn |
2296-2646 |
publishDate |
2019-07-01 |
description |
The human Sigma1 receptor (S1R), which has been identified as a target with an important role in neuropsychological disorders, was first crystallized 3 years ago. Since S1R structure has no relation with another previous crystallized structures, the presence of the new crystal is an important hallmark for the design of agonists and antagonists against this important target. Some years ago, our group identified RC-33, a potent and selective S1R agonist, endowed with neuroprotective properties. In this work, drawing on new structural information, we studied the interactions of RC-33 and its analogs with the S1R binding site by using computational methods such as docking, interaction fingerprints, and receptor-guided alignment three dimensional quantitative structure–activity relationship (3D-QSAR). We found that RC-33 and its analogs adopted similar orientations within S1R binding site, with high similitude with orientations of the crystallized ligands; such information was used for identifying the residues involved in chemical interactions with ligands. Furthermore, the structure-activity relationship of the studied ligands was adequately described considering classical QSAR tests. All relevant aspects of the interactions between the studied compounds and S1R were covered here, through descriptions of orientations, binding interactions, and features that influence differential affinities. In this sense, the present results could be useful in the future design of novel S1R modulators. |
topic |
sigma1 receptor ligands RC-33 arylalkylamine derivates docking quantitative structure–activity relationships interaction fingerprints |
url |
https://www.frontiersin.org/article/10.3389/fchem.2019.00496/full |
work_keys_str_mv |
AT joseluisvelazquezlibera dockinginteractionfingerprintandthreedimensionalquantitativestructureactivityrelationship3dqsarofsigma1receptorligandsanalogsoftheneuroprotectiveagentrc33 AT giacomorossino dockinginteractionfingerprintandthreedimensionalquantitativestructureactivityrelationship3dqsarofsigma1receptorligandsanalogsoftheneuroprotectiveagentrc33 AT carlosnavarroretamal dockinginteractionfingerprintandthreedimensionalquantitativestructureactivityrelationship3dqsarofsigma1receptorligandsanalogsoftheneuroprotectiveagentrc33 AT simonacollina dockinginteractionfingerprintandthreedimensionalquantitativestructureactivityrelationship3dqsarofsigma1receptorligandsanalogsoftheneuroprotectiveagentrc33 AT juliocaballero dockinginteractionfingerprintandthreedimensionalquantitativestructureactivityrelationship3dqsarofsigma1receptorligandsanalogsoftheneuroprotectiveagentrc33 |
_version_ |
1725033139201376256 |